Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IRESSA Novel Head and Neck Chemotherapy Evaluation Study
NCT00255476Phase 2Completed
- Sponsor
- AstraZeneca
- Start
- Feb 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of gefitinib in squamous cell carcinoma of the head and neck (HNSCC), sponsored by AstraZeneca. Started Feb 2004; status: completed.
02
Drugs
03
Conditions
squamous cell carcinoma of the head and neck (HNSCC)
Beyond the preview
Go deeper on NCT00255476.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00255476.